J&J takes Carlyle's $4B offer for its Ortho Diagnostics unit

Johnson & Johnson ($JNJ) agreed to unload its Ortho Clinical Diagnostics unit to the private equity firm Carlyle Group in a $4.15 billion deal. J&J said last year it wanted to shed the underperforming business, and analysts now predict that the company will put other business units on the block. Report